Mineralys Therapeutics Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Mineralys Therapeutics Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
MLYS
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001933414

Board of directors

Follow this board

Chief executives

Jon Congleton · Chief Executive Officer
Dates unknown

Board connections

7 of this board's directors also sit on 32 other boards.

Network of Mineralys Therapeutics Inc.'s board connections Acrivon Therapeutics Inc. Acrivon Therapeutics I... Evommune Inc. Evommune Inc. Werewolf Therapeutics Inc. Werewolf Therapeutics... ARS Pharmaceuticals Inc. ARS Pharmaceuticals In... Acumen Pharmaceuticals Inc. Acumen Pharmaceuticals... Artiva Biotherapeutics Inc. Artiva Biotherapeutics... Bicara Therapeutics Inc. Bicara Therapeutics In... Black Diamond Therapeutics Inc. Black Diamond Therapeu... Climb Bio Inc. Climb Bio Inc. Freenome Inc. Freenome Inc. Hemab Therapeutics Holdings Inc. Hemab Therapeutics Hol... Jade Biosciences Inc. Jade Biosciences Inc. Janux Therapeutics Inc. Janux Therapeutics Inc... LENZ Therapeutics Inc. LENZ Therapeutics Inc. Nkarta Inc. Nkarta Inc. Parabilis Medicines Inc. Parabilis Medicines In... Derek DiRocco Derek DiRocco Peter Kolchinsky Peter Kolchinsky Rajeev M. Shah Rajeev M. Shah Mineralys Therapeutics Inc...
Shared director Other board Same sector +16 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$8,762,797
2 purchases by 1 insider
Sold, last 12 months
$87,638,449
84 sales by 7 insiders
Date Insider Transaction Shares Price Value
Sep 22, 2026 Brian Taylor Slingsby Director Open-market sale −104,320 $28.81 $3,005,303
Sep 21, 2026 Warren Eric Officer (Chief Commercial Officer) Option exercise +7,438 $13.24 $98,479
Sep 21, 2026 Warren Eric Officer (Chief Commercial Officer) Open-market sale −7,438 $28.12 $209,136
Sep 15, 2026 Daphne Karydas Director Option exercise +3,000 $12.02 $36,060
Sep 15, 2026 Daphne Karydas Director Open-market sale −3,000 $28.58 $85,740
Aug 21, 2026 Warren Eric Officer (Chief Commercial Officer) Option exercise +7,437 $13.24 $98,466
Aug 21, 2026 Warren Eric Officer (Chief Commercial Officer) Open-market sale −7,437 $25.98 $193,189
Aug 10, 2026 Ferguson James J. III Officer (Chief Medical Officer) Grant or award +102,400 — —
Aug 10, 2026 Rodman David Malcom Officer (Chief Medical Officer) Option exercise +2,170 $16.00 $34,720
Aug 10, 2026 Rodman David Malcom Officer (Chief Medical Officer) Open-market sale −2,170 $27.09 $58,785
Jul 21, 2026 Warren Eric Officer (Chief Commercial Officer) Option exercise +7,438 $13.24 $98,479
Jul 21, 2026 Warren Eric Officer (Chief Commercial Officer) Open-market sale −7,438 $26.87 $199,885
Jul 17, 2026 Rodman David Malcom Officer (Chief Medical Officer) Option exercise +416 $15.44 $6,423
Jul 17, 2026 Rodman David Malcom Officer (Chief Medical Officer) Open-market sale −416 $26.53 $11,036
Jul 15, 2026 Rodman David Malcom Officer (Chief Medical Officer) Open-market sale −6,349 $26.61 $168,955

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.